Get the Stockscreener App
2.88
5.26%
-0.16
Pre-market:
2.90
0.02
+0.69%
Revelation Biosciences Inc stock is traded at $2.88, with a volume of 207.66K.
It is down -5.26% in the last 24 hours and up +243.27% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$3.04
Open:
$2.96
24h Volume:
207.66K
Relative Volume:
0.20
Market Cap:
$4.67M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.155
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-2.37%
1M Performance:
+243.27%
6M Performance:
-26.71%
1Y Performance:
-88.89%
1-Day Range:
$2.80
$2.99
1-Week Range:
$2.80
$3.22
52-Week Range:
$0.702
$56.00
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
2.88 | 4.67M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Stock (REVB) Latest News
Is Revelation Biosciences Inc. Equity Warrant a growth stock or a value stockAchieve exceptional returns with expert guidance - jammulinksnews.com
Is Revelation Biosciences Inc. Equity Warrant stock overvalued or undervaluedMaximize your returns with expert insights - jammulinksnews.com
What is the dividend policy of Revelation Biosciences Inc. Equity Warrant stockExplosive portfolio gains - jammulinksnews.com
Why is Revelation Biosciences Inc. stock attracting strong analyst attentionJaw-dropping returns - jammulinksnews.com
What are the technical indicators suggesting about Revelation Biosciences Inc.Achieve breakthrough results with expert guidance - jammulinksnews.com
What catalysts could drive Revelation Biosciences Inc. stock higher in 2025Tap into rapid wealth building techniques - jammulinksnews.com
Why is Revelation Biosciences Inc. Equity Warrant stock attracting strong analyst attentionRapid capital growth - jammulinksnews.com
What makes Revelation Biosciences Inc. stock price move sharplyBuild capital through low-risk investments - jammulinksnews.com
Does Revelation Biosciences Inc. stock perform well during market downturnsHigh-yield investments - jammulinksnews.com
What are the technical indicators suggesting about Revelation Biosciences Inc. Equity WarrantInvest smarter with expert stock picks - jammulinksnews.com
How volatile is Revelation Biosciences Inc. Equity Warrant stock compared to the marketCapitalize on emerging investment opportunities - jammulinksnews.com
What institutional investors are buying Revelation Biosciences Inc. stockBuild a portfolio that stands the test of time - jammulinksnews.com
Will Revelation Biosciences Inc. Stock Benefit from AI and Green Energy TrendsFree Capital Growth Strategies - Newser
When is the best time to buy REVB stockCapital Safe Stock Watchlist - Newser
Moving Average Trends for Revelation Biosciences Inc. Stock: What They IndicateTriple Digit Return Forecasts - Newser
Revelation Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Selection with 300% Return - Newser
Why Revelation Biosciences Inc. Equity Warrant stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
why revelation biosciences inc. stock attracts strong analyst attentionCapital Safe Stock Watchlist - Newser
What analysts say about Revelation Biosciences Inc. Equity Warrant stock outlookTremendous wealth creation - jammulinksnews.com
What drives Revelation Biosciences Inc. Equity Warrant stock priceSuperior return velocity - Autocar Professional
Is Revelation Biosciences Inc. Equity Warrant a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
Is Revelation Biosciences Inc. stock a growth or value playMassive wealth growth - jammulinksnews.com
What analysts say about Revelation Biosciences Inc. stockSkyrocketing returns - PrintWeekIndia
Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research - Business Wire
What analysts say about Revelation Biosciences Inc. Equity Warrant stockFree Market Dynamics Reports - Autocar Professional
Revelation Biosciences Inc. Equity Warrant Stock Analysis and ForecastSuperior profit margins - jammulinksnews.com
What drives Revelation Biosciences Inc. stock priceConsistent triple-digit returns - jammulinksnews.com
Is Revelation Biosciences Inc. a good long term investmentRapid-fire capital growth - jammulinksnews.com
Revelation Biosciences Inc. Stock Analysis and ForecastExplosive trading opportunities - jammulinksnews.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):